SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-24-008548
Filing Date
2024-01-31
Accepted
2024-01-31 08:00:28
Documents
1
Group Members
ADAR1 CAPITAL MANAGEMENT GP, LLCADAR1 CAPITAL MANAGEMENT, LLCDANIEL SCHNEEBERGER

Document Format Files

Seq Description Document Type Size
1 SC 13G tm244656d1_sc13g.htm SC 13G 104916
  Complete submission text file 0001104659-24-008548.txt   106779
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85798 | Film No.: 24580667
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738
Business Address 325 RANCH ROAD 620 SOUTH, SUITE 200 AUSTIN TX 78738 512-531-9088
ADAR1 Partners, LP (Filed by) CIK: 0001758866 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G